Jazz Pharmaceuticals (JAZZ) EBT Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 48.67% |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn | 75.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 75.77% |
| Dec 31, 2025 | 37.74% |
| Sep 30, 2025 | 29.07% |
| Jun 30, 2025 | -233.23% |
| Mar 31, 2025 | -168.51% |
| Dec 31, 2024 | 70.67% |
| Sep 30, 2024 | 70.64% |
| Jun 30, 2024 | 44.44% |
| Mar 31, 2024 | -26.24% |
| Dec 31, 2023 | -24.82% |
| Sep 30, 2023 | -16.04% |
| Jun 30, 2023 | -21.87% |
| Mar 31, 2023 | 31.29% |
| Dec 31, 2022 | -117.86% |
| Sep 30, 2022 | -36.20% |
| Jun 30, 2022 | -51.49% |
| Mar 31, 2022 | -61.99% |
| Dec 31, 2021 | -31.44% |
| Sep 30, 2021 | -33.89% |
| Jun 30, 2021 | -45.04% |
| Mar 31, 2021 | 27.49% |
| Dec 31, 2020 | 6.78% |
| Sep 30, 2020 | 37.25% |
| Jun 30, 2020 | 6.65% |
| Mar 31, 2020 | -56.14% |
| Dec 31, 2019 | -35.41% |
| Sep 30, 2019 | -0.62% |
| Jun 30, 2019 | 5.54% |
| Mar 31, 2019 | 2.13% |
| Dec 31, 2018 | 19.68% |
| Sep 30, 2018 | 12.77% |
| Jun 30, 2018 | 2.91% |
| Mar 31, 2018 | -13.95% |
| Dec 31, 2017 | 1.05% |
| Sep 30, 2017 | 9.17% |
| Jun 30, 2017 | 30.95% |
| Mar 31, 2017 | 52.00% |
| Sep 30, 2016 | 7.47% |
| Jun 30, 2016 | 33.52% |
| Mar 31, 2016 | 20.99% |
| Dec 31, 2015 | 18.88% |
| Sep 30, 2015 | 36.41% |
| Jun 30, 2015 | 46.58% |
| Mar 31, 2015 | 42.18% |
| Dec 31, 2014 | 45.42% |
| Sep 30, 2014 | 15.45% |
| Jun 30, 2014 | 23.76% |
| Mar 31, 2014 | -76.62% |
| Sep 30, 2013 | 92.01% |
| Jun 30, 2013 | 85.36% |